Nautilus Biotechnology (NAUT) Retained Earnings (2020 - 2026)

Nautilus Biotechnology has disclosed Retained Earnings across 7 years of filings, most recently posting -$346.7 million for Q1 2026.

• Retained Earnings for Q1 2026 came in at -$346.7 million, down 19.7% year-over-year; the trailing twelve-month figure through Mar 2026 was -$346.7 million (down 19.7% YoY), and the FY2025 annual result was $243000.0, up 326.32% from the prior year.
• Retained Earnings came in at -$346.7 million for Q1 2026 at Nautilus Biotechnology, down from $243000.0 in the prior quarter.
• In the past five years, Retained Earnings ranged from a high of $243000.0 in Q4 2025 to a low of -$346.7 million in Q1 2026.
• The 5-year median for Retained Earnings is -$138.6 million (2022), against an average of -$135.0 million.
• Across the five-year window, Retained Earnings slumped 1110820.0% in 2022 and jumped 326.32% in 2025, its largest moves.
• Nautilus Biotechnology's Retained Earnings stood at -$138.6 million in 2022, then tumbled by 45.95% to -$202.2 million in 2023, then surged by 100.03% to $57000.0 in 2024, then soared by 326.32% to $243000.0 in 2025, then tumbled by 142774.9% to -$346.7 million in 2026.
• The last three Retained Earnings figures came in at -$346.7 million (Q1 2026), $243000.0 (Q4 2025), and $200000.0 (Q3 2025), per Business Quant data.